logo-loader
viewBiotechnology Innovation Organization (BIO)

BIO VP of Industry Research reveals recent findings in chronic disease report

BIO Vice President of Industry Research David Thomas sat down with Proactive at the BIO CEO & Investor Conference.

Thomas recently released a new report detailing findings in chronic disease, and is set to speak at BIO's panel on cardiovascular diseases.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: XPhyto sees Germany as key market as they announce deal with...

XPhyto (CSE: XPHY- OTC: XPHYF) CEO Hugh Rogers and Bunker, Managing Director Wolfgang Probst joined Steve Darling from Proactive Vancouver to share news the company has signed a deal with German Brewer Oettinger development, production, and distribution of cannabis-infused beverages and...

2 days, 3 hours ago

2 min read